R Rampling
Impact in
Papers in
- Co-authors
- Donald M. Hadley (5 shared papers)Vakis Papanastassiou (4 shared papers)J. Harland (4 shared papers)Richard Petty (3 shared papers)James A. R. Nicoll (5 shared papers)M. Brown (2 shared papers)G. Cruickshank (5 shared papers)Matthew Fraser (2 shared papers)
- Journals
- British Journal of Cancer (7 papers)Clinical Oncology (4 papers)Gene Therapy (3 papers)Journal of Neuro-Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
R Rampling
48 papers receiving 2.7k citations
R Rampling's Hit Papers
Peers
Comparison fields: 5 of 106
- Genetics 598
- Genetics 1.1k
- Neurology 483
- Oncology 729
- Cancer Research 259
Countries citing papers authored by R Rampling
This map shows the geographic impact of R Rampling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Rampling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Rampling more than expected).
Fields of papers citing papers by R Rampling
This network shows the impact of papers produced by R Rampling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Rampling. The network helps show where R Rampling may publish in the future.
Co-authors
The 25 scholars most cited alongside R Rampling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma Hit paper breakdown → | 2000 | 512 |
| 2 | 2002 | 281 | |
| 3 | 2004 | 279 | |
| 4 | 1994 | 259 | |
| 5 | 1987 | 175 | |
| 6 | A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. | 2000 | 149 |
| 7 | 2000 | 135 | |
| 8 | 1996 | 123 | |
| 9 | 1996 | 102 | |
| 10 | 1991 | 83 | |
| 11 | 1991 | 80 | |
| 12 | 2004 | 56 | |
| 13 | 1986 | 48 | |
| 14 | 1998 | 47 | |
| 15 | 1994 | 47 | |
| 16 | 1997 | 46 | |
| 17 | Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks. | 1997 | 43 |
| 18 | 2000 | 41 | |
| 19 | 1987 | 35 | |
| 20 | 2006 | 34 |
About R Rampling
R Rampling is a scholar working on Genetics, Neurology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 49 papers that have together received 2.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (17 papers), Virus-based gene therapy research (8 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Herpesvirus Infections and Treatments (5 papers), Brain Metastases and Treatment (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Neuroblastoma Research and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Genetics (598 citations), Genetics (1.1k citations), Neurology (483 citations), Oncology (729 citations) and Cancer Research (259 citations). R Rampling has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Donald M. Hadley, Vakis Papanastassiou, J. Harland, Richard Petty, James A. R. Nicoll, M. Brown, G. Cruickshank, Matthew Fraser, Paul Workman and E. A. McKie. Their work appears in journals such as British Journal of Cancer, Clinical Oncology, Gene Therapy, Journal of Neuro-Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.